Bipul Kumar

Bipul Kumar

Active Director Director DIN 02741316
DIN 02741316 First appointment Aug 2009 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2009
Shareholding value •••• Premium profile

About Bipul Kumar

Data last updated:

Bipul Kumar is a Director at Lukem Pharmaceuticals Private Limited (since 2009). The company operates in Trading. Lukem Pharmaceuticals Private Limited reported revenue of ₹10.7 Lakh (FY 2025).

DIN 02741316
Primary Designation Director
Industry Trading
First Appointment 28 Aug 2009
Oldest Company Age 17 yrs
Largest company Lukem Pharmaceuticals Private Limited · ₹10.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Aug 20092009₹10.7 Lakh (FY 2025)Active

Board colleagues of Bipul Kumar

NameDINCompanyDesignation
Abhishek Sharma02734633Lukem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lukem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bipul Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bipul Kumar

Bipul Kumar currently holds 1 directorship: Lukem Pharmaceuticals Private Limited (Director, since 28 Aug 2009, revenue ₹10.7 Lakh (FY 2025)).

Bipul Kumar was first appointed on 28 Aug 2009 as Director at Lukem Pharmaceuticals Private Limited.

The current boards of Bipul Kumar's companies include Abhishek Sharma (Lukem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available